Literature DB >> 24999029

Secondary hyperoxaluria: a risk factor for kidney stone formation and renal failure in native kidneys and renal grafts.

Georgios Karaolanis1, Sophia Lionaki2, Demetrios Moris3, Viktoria-Varvara Palla3, Spiridon Vernadakis3.   

Abstract

Secondary hyperoxaluria is a multifactorial disease affecting several organs and tissues, among which stand native and transplanted kidneys. Nephrocalcinosis and nephrolithiasis may lead to renal insufficiency. Patients suffering from secondary hyperoxaluria, should be promptly identified and appropriately treated, so that less renal damage occurs. The aim of this review is to underline the causes of hyperoxaluria and the related pathophysiologic mechanisms, which are involved, along with the description of seven cases of irreversible renal graft injury due to secondary hyperoxaluria.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Year:  2014        PMID： 24999029     DOI： 10.1016/j.trre.2014.05.004

Source DB:  PubMed          Journal:  Transplant Rev (Orlando)        ISSN： 0955-470X            Impact factor:   3.943


  12 in total

1.  Mitochondria Permeability Transition versus Necroptosis in Oxalate-Induced AKI.

Authors:  Shrikant Ramesh Mulay; Mohsen M Honarpisheh; Orestes Foresto-Neto; Chongxu Shi; Jyaysi Desai; Zhi Bo Zhao; Julian A Marschner; Bastian Popper; Ewa Miriam Buhl; Peter Boor; Andreas Linkermann; Helen Liapis; Rostyslav Bilyy; Martin Herrmann; Paola Romagnani; Ilya Belevich; Eija Jokitalo; Jan U Becker; Hans-Joachim Anders
Journal:  J Am Soc Nephrol       Date:  2019-07-11       Impact factor: 10.121

Review 2.  Primary and secondary hyperoxaluria: Understanding the enigma.

Authors:  Bhavna Bhasin; Hatice Melda Ürekli; Mohamed G Atta
Journal:  World J Nephrol       Date:  2015-05-06

3.  A Prospective, Double-Blind, Randomized, Placebo-Controlled, Crossover Study Using an Orally Administered Oxalate Decarboxylase (OxDC).

Authors:  Emily Quintero; Victoria Yvonne Bird; Howard Liu; Gary Stevens; Alan S Ryan; Sabrina Buzzerd; Ira W Klimberg
Journal:  Kidney360       Date:  2020-09-03

Review 4.  Lumasiran in the Management of Patients with Primary Hyperoxaluria Type 1: From Bench to Bedside.

Authors:  Viola D'Ambrosio; Pietro Manuel Ferraro
Journal:  Int J Nephrol Renovasc Dis       Date:  2022-06-17

Review 5.  Oxalate nephropathy in systemic sclerosis: Case series and review of the literature.

Authors:  Colin B Ligon; Laura K Hummers; Zsuzsanna H McMahan
Journal:  Semin Arthritis Rheum       Date:  2015-07-02       Impact factor: 5.532

6.  Pathophysiology and Treatment of Enteric Hyperoxaluria.

Authors:  Celeste Witting; Craig B Langman; Dean Assimos; Michelle A Baum; Annamaria Kausz; Dawn Milliner; Greg Tasian; Elaine Worcester; Meaghan Allain; Melissa West; Felix Knauf; John C Lieske
Journal:  Clin J Am Soc Nephrol       Date:  2020-09-08       Impact factor: 8.237

7.  A hidden cause of oxalate nephropathy: a case report.

Authors:  Tala Mahmoud; Elias C Ghandour; Bernard G Jaar
Journal:  J Med Case Rep       Date:  2021-03-08

Review 8.  Renal injury, nephrolithiasis and Nigella sativa: A mini review.

Authors:  Parichehr Hayatdavoudi; Abolfazl Khajavi Rad; Ziba Rajaei; Mousa Al-Reza Hadjzadeh
Journal:  Avicenna J Phytomed       Date:  2016 Jan-Feb

9.  A Successful Approach to Kidney Transplantation in Patients With Enteric (Secondary) Hyperoxaluria.

Authors:  Joke I Roodnat; Anneke M E de Mik-van Egmond; Wesley J Visser; Stefan P Berger; Wilbert A G van der Meijden; Felix Knauf; Madelon van Agteren; Michiel G H Betjes; Ewout J Hoorn
Journal:  Transplant Direct       Date:  2017-11-08

10.  Inhibitors of Calcium Oxalate Crystallization for the Treatment of Oxalate Nephropathies.

Authors:  Anna Kletzmayr; Shrikant R Mulay; Manga Motrapu; Zhi Luo; Hans-Joachim Anders; Mattias E Ivarsson; Jean-Christophe Leroux
Journal:  Adv Sci (Weinh)       Date:  2020-02-27       Impact factor: 16.806
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.